Avidity Partners Management LP Iveric Bio, Inc. Transaction History

Avidity Partners Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$18.67 - $24.56 $19.2 Million - $25.3 Million	1,030,793 Added 122.95%	1,869,200 $45.5 Million
Q4 2022 Feb 14, 2023	BUY	$17.24 - $23.95 $14.5 Million - $20.1 Million	838,407 New	838,407 $18 Million
Q2 2022 Aug 15, 2022	SELL	$9.12 - $18.9 $55.1 Million - $114 Million	-6,045,283 Reduced 93.36%	430,117 $4.14 Million
Q1 2022 May 16, 2022	SELL	$12.15 - $16.83 $5.83 Million - $8.07 Million	-479,600 Reduced 6.9%	6,475,400 $109 Million
Q4 2021 Feb 14, 2022	BUY	$13.83 - $18.78 $39.5 Million - $53.6 Million	2,855,000 Added 69.63%	6,955,000 $116 Million
Q3 2021 Nov 15, 2021	BUY	$7.07 - $17.5 $19.1 Million - $47.2 Million	2,699,990 Added 192.86%	4,100,000 $66.6 Million
Q2 2021 Aug 16, 2021	BUY	$5.69 - $7.17 $7.97 Million - $10 Million	1,400,010 New	1,400,010 $8.83 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.